LUNG NEUROENDOCRINE TUMOR
Clinical trials for LUNG NEUROENDOCRINE TUMOR explained in plain language.
Never miss a new study
Get alerted when new LUNG NEUROENDOCRINE TUMOR trials appear
Sign up with your email to follow new studies for LUNG NEUROENDOCRINE TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immunotherapy duo takes on rare tumors in major trial
Disease control OngoingThis study tests whether combining two immunotherapy drugs, nivolumab and ipilimumab, can shrink tumors in people with rare cancers. About 800 participants with over 50 different rare tumor types received these drugs to boost their immune system's ability to fight cancer. The goa…
Matched conditions: LUNG NEUROENDOCRINE TUMOR
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 15, 2026 19:03 UTC
-
New drug shows promise in slowing advanced neuroendocrine tumors
Disease control OngoingThis study tests whether the drug cabozantinib can slow the growth of advanced neuroendocrine tumors (including carcinoid tumors) compared to a placebo. About 298 adults whose cancer worsened after prior treatment will receive either cabozantinib or a placebo pill. The main goal …
Matched conditions: LUNG NEUROENDOCRINE TUMOR
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 12, 2026 12:08 UTC